{
    "clinical_study": {
        "@rank": "58873", 
        "arm_group": {
            "arm_group_label": "testosterone", 
            "arm_group_type": "Experimental", 
            "description": "testosterone gel per day for 6 months testosterone 250 mg injection  per 3-4 weeks for 6 months"
        }, 
        "brief_summary": {
            "textblock": "The study is designed to answer the following questions:\n\n        1. What is the levels of visceral adiposity index and Triglycerides/HDL     cholesterol\n           ratio in hypogonadism?\n\n        2. What is the effect of testosterone replacement on the visceral adiposity index and\n           Triglycerides/HDL cholesterol ratio?"
        }, 
        "brief_title": "Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism and Effect of Testosteron Treatment", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Hypogonadism", 
        "condition_browse": {
            "mesh_term": [
                "Hypogonadism", 
                "Obesity"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a retrospective design, which is performed by investigating the registrations of\n      patients with hypogonadotrophic hypogonadism between the years 2007-2010."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men\n\n          -  Congenital hypogonadism\n\n          -  Treatment Naive\n\n        Exclusion Criteria:\n\n          -  Previous history of androgen replacement\n\n          -  Hypertension\n\n          -  Diabetes mellitus"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "26 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02111434", 
            "org_study_id": "GSM-022014"
        }, 
        "intervention": {
            "arm_group_label": "testosterone", 
            "description": "Testosterone 250 mg injection per 3-4 weeks for 6 months", 
            "intervention_name": "Testosterone", 
            "intervention_type": "Drug", 
            "other_name": "sustanon 250 mg"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "visceral adiposity index", 
            "triglycerides / hdl cholesterol ratio", 
            "testosterone"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ankara", 
                    "country": "Turkey", 
                    "zip": "06018"
                }, 
                "name": "Gulhane School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 4 Study of Effect of Testosteron Treatment on the Visceral Adiposity Index and Triglyceride/High-density Lipoprotein Cholesterol Ratio in the Congenital Hypogonadotropic Hypogonadism", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "time to change of visceral adiposity index with testosteron replacement", 
                "safety_issue": "No", 
                "time_frame": "baseline and 6 months"
            }, 
            {
                "measure": "time to change of  TG/HDL cholesterol ratio with testosteron replacement", 
                "safety_issue": "No", 
                "time_frame": "baseline and 6 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02111434"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Gulhane School of Medicine", 
            "investigator_full_name": "cem haymana", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Gulhane School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gulhane School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}